2020
DOI: 10.1080/03009734.2020.1751751
|View full text |Cite
|
Sign up to set email alerts
|

Adjuvants in IVF—evidence for what works and what does not work

Abstract: The field of assisted reproductive technology is shaped and changed constantly by advances in science and cutting-edge innovations. In a quest to maximise outcomes, add-on interventions are often adopted and utilised prematurely while the principles of evidence-based medicine seem to be less strictly adhered to. In this review we will attempt to summarise the latest evidence about some of the adjuvants.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
7
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 61 publications
0
7
0
Order By: Relevance
“…Due to the adverse influence of aging, an “add-on” or adjuvant medical intervention is commonly given, either alone or in combination, to the standard protocol of IVF to improve outcomes [ 31 , 32 ]. LH and GH are two substances ubiquitously utilized for this purpose.…”
Section: Discussionmentioning
confidence: 99%
“…Due to the adverse influence of aging, an “add-on” or adjuvant medical intervention is commonly given, either alone or in combination, to the standard protocol of IVF to improve outcomes [ 31 , 32 ]. LH and GH are two substances ubiquitously utilized for this purpose.…”
Section: Discussionmentioning
confidence: 99%
“…It is especially useful in patient groups who are thought to have immunological infertility in recurrent implantation failure. Because there is the idea that changes in Th1/Th2 balance and increases in uterine NK cell count may play a role in infertility in these patient groups (23). On the other hand, combined immunosuppression may increase implantation, as immunological factors often include thyroid or ovarian auto-antibodies.…”
Section: To Improve Endometrial Quality and Implantationmentioning
confidence: 99%
“…The increasing use of adjuvant therapies in ART, most of which prove useless when seriously tested, is discussed in the paper by Nardo et al (9). This is an important field, as the commercialization of ART promotes competition between clinics, a competition that often includes offers of various adjuncts.…”
Section: Editorialmentioning
confidence: 99%